Search
Pimitespib
go.drugbank.com/drugs/DB14876InvestigationalTAS-116 is under investigation in clinical trial NCT02965885 (A Study of TAS-116 in Patients With Solid Tumors).
Posdinemab
go.drugbank.com/drugs/DB18941InvestigationalPosdinemab is under investigation in clinical trial NCT04619420 (A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease).
TAK-071
go.drugbank.com/drugs/DB18954InvestigationalTAK-071 is under investigation in clinical trial NCT04334317 (A Study of TAK-071 in People With Parkinson Disease).
Rezpegaldesleukin
go.drugbank.com/drugs/DB18992InvestigationalRezpegaldesleukin is under investigation in clinical trial NCT04433585 (A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)).
Bovhyaluronidase azoximer
go.drugbank.com/drugs/DB19020InvestigationalBovhyaluronidase azoximer is under investigation in clinical trial NCT06458543 (Optimization of Bacterial Vaginosis Treatment in Women of Reproductive Age).
Minigastrin
go.drugbank.com/drugs/DB19196InvestigationalMinigastrin is under investigation in clinical trial NCT06155994 (68ga-dota-mgs5 PET/CT in Patients With Advanced Neuroendocrine Tumours).
Synonyms: L-phenylalaninamide, l-leucyl-l-.alpha.-aspartyl-l-.alpha.-aspartyl-l-.alpha.-aspartyl-l-.alpha.-aspartyl-l-.alpha.-aspartyl-l-alanyl-l-tyrosylglycyl-l-tryptophyl-l-leucyl-l-.alpha.-aspartyl-Exidavnemab
go.drugbank.com/drugs/DB19452InvestigationalExidavnemab is under investigation in clinical trial NCT06671938 (Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease).
TAK-653
go.drugbank.com/drugs/DB16304InvestigationalTAK-653 is under investigation in clinical trial NCT03312894 (Efficacy and Safety of TAK-653 in Treatment-resistant Depression).
GI heptapeptide
go.drugbank.com/drugs/DB15070InvestigationalGI heptapeptide is under investigation in clinical trial NCT01391208 (Esophageal Protocol for Detection of Neoplasia in the Digestive Tract).
ELX-02
go.drugbank.com/drugs/DB15080InvestigationalELX-02 is under investigation in clinical trial NCT03309605 (Phase 1 Study of ELX-02 in Healthy Adult Subjects).